PATENT CLAIM ANALYSIS

Application Number: 15889917
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "094630"]

Abstract:
A therapeutic agent for the treatment of toxemia, preeclampsia and eclampsia and a method for preparing the therapeutic agent are disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or by other methods. Further, a method of using the presence of chymotrypsin in the maternal GI tract as a biomarker, to determine the likelihood of developing preeclampsia, a pregnancy induced hypertension, and eclampsia/toxemia is disclosed.

Claim (Index 24):
The method of  claim 17 , wherein the amount of protease ranges from 10,000 to 70,000 USP units/dose.

Metadata:
- Claim Count in Document: 86.0
- Percentile: 88.0
- Lexical Diversity: 1.76923
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14037696', '12047818', '15185511', '13926822', '11317378']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6601359837702099
- 35 USC 102 Novelty (BERT): 0.6086525289863236
- Combined Prediction Score: 0.6549876382918213
- Mean Citation Score: 443.847616
- Max Citation Score: 567.7696
- Similarity Product: 452.727565460205

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test